Clinical characteristics and management of acute cholecystitis after cardiovascular surgery

Koya Yasukawa,Akira Shimizu,Koji Kubota,Tsuyoshi Notake,Shinsuke Sugenoya,Kiyotaka Hosoda,Hikaru Hayashi,Ryoichiro Kobayashi,Yuji Soejima
DOI: https://doi.org/10.1002/jhbp.872
Abstract:Background: Acute cholecystitis (AC) is a severe complication after cardiovascular surgery (CS). The purpose of this study was to delineate the clinical picture of AC after CS to propose an optimal treatment strategy. Methods: We retrospectively reviewed the records of 88 patients who underwent cholecystectomy for grade II or III AC between 2008 and 2019 (AC after CS: Group CS, n = 37; AC without CS: Group non-CS, n = 51). Results: The proportion of grade III AC in Group CS was significantly higher than that in Group non-CS (73% vs 41%, P = .005). Furthermore, the incidences of acalculous (81% vs 39%) and gangrenous (86% vs 59%) AC were significantly higher in Group CS (P < .05 for both). In Group CS, 11 patients had had percutaneous drainage preceding surgery, for whom cholecystectomy within 3 days was eventually necessary because their general condition was exacerbated. The incidence of a positive culture from the gallbladder bile and blood samples of Group CS were significantly higher (P < .05 for both); multidrug-resistant bacteria were detected at an especially high rate. However, the morbidity rate was comparable, and zero mortality was achieved in both groups. Conclusions: Timely surgical intervention without hesitation is recommended for AC after CS.
What problem does this paper attempt to address?